People: CorMedix Inc (CRMD.K)

CRMD.K on American Stock Exchange

1.82USD
11 Jul 2014
Price Change (% chg)

$-0.03 (-1.82%)
Prev Close
$1.85
Open
$1.80
Day's High
$1.87
Day's Low
$1.79
Volume
29,301
Avg. Vol
100,172
52-wk High
$3.20
52-wk Low
$0.66

Search Stocks

Pfaffle, Antony 

Brief Biography

Dr. Antony E. Pfaffle, M.D., has been appointed as Vice Chairman of the Board of CorMedix Inc., effective August 14, 2013. He has been appointed as Acting Chief Scientific Officer of the company effective January 1, 2013.Dr. Pfaffle has been Director of Healthcare Research at Bearing Circle Capital, L.P., an investment fund, since May 2007. Dr. Pfaffle is an Advisory Medical Director for ParagonRx, an Inventiv Company specializing in drug and device risk evaluation and mitigation. He was a Managing Director at Paramount BioCapital, Inc. and Senior Vice-President of Business Development at Paramount BioSciences, LLC from December 2005 to May 2007. Dr. Pfaffle was a Principal and Founder of Black Diamond Research, an investment research company, from July 2001 to December 2005. Dr. Pfaffle is an internist who practiced nephrology at New York Hospital-Weill Cornell Medical Center, Lenox Hill Hospital and Memorial Sloan-Kettering Cancer Center. Dr. Pfaffle received his M.D. from New York Medical College in 1989. Among other experience, qualifications, attributes and skills, Dr. Pfaffle’s financial expertise, knowledge of the investment community, medical science background and experience with development stage biopharmaceutical companies led to the conclusion of our Board that he should serve as a director of our company in light of our business and structure.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
120,000 -- 192,270 312,270

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks